Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Journal of Colorado.
Press releases published on April 2, 2025
Netcoins Launches Innovative New Web Trading App
GlobeNewswire
·
April 2, 2025
VANCOUVER, British Columbia, April 02, 2025 (GLOBE NEWSWIRE) -- BIGG Digital Assets Inc. (“BIGG” or the “Company”) (TSXV: BIGG; OTCQX: BBKCF; WKN: A2PS9W), a leading innovator in the digital assets space and owner of Netcoins, Blockchain Intelligence Group …
FibroBiologics Announces Scientific Advancement in Confirmation Results of Brain Tissue Repair
GlobeNewswire
·
April 2, 2025
HOUSTON, April 02, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics”), a clinical-stage biotechnology company with 240+ patents issued and pending for the development of therapeutics and potential cures for chronic diseases …
CorMedix Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire
·
April 2, 2025
BERKELEY HEIGHTS, N.J., April 02, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that …
authID Announces Closing of $8,150,000 Registered Direct Offering
GlobeNewswire
·
April 2, 2025
DENVER, April 02, 2025 (GLOBE NEWSWIRE) -- authID Inc. (NASDAQ: AUID) (“authID” or the “Company”), a leading provider of biometric identity verification and authentication solutions, today announced it has closed its previously announced transaction with …
Delinea Partners with Microsoft to Ensure Seamless Transition and Continued Security as Microsoft Entra Permissions Management Retires
GlobeNewswire
·
April 2, 2025
SAN FRANCISCO, April 02, 2025 (GLOBE NEWSWIRE) -- Delinea, a pioneering provider of solutions for securing human and machine identities through centralized authorization, has partnered with Microsoft to assist Microsoft Entra Permissions Management …
Celona Extends its Neutral Host Service to Millions of AT&T Customers
GlobeNewswire
·
April 2, 2025
CAMPBELL, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- Celona, a pioneer in private 5G networks, today announced the expansion of its industry leading neutral host solution with the addition of AT…
Denali Therapeutics Announces Initiation of BLA Filing for Accelerated Approval of Tividenofusp Alfa for the Treatment of Hunter Syndrome (MPS II) and Positive Ongoing Interactions with FDA on DNL126 Through START Program
GlobeNewswire
·
April 2, 2025
Rolling submission of BLA initiated for tividenofusp alfa; preparations ongoing for potential U.S. commercial launch in late 2025 or early 2026 Alignment through recent interactions with CDER on path to accelerated approval and conversion to full approval …
Immunocore to present at upcoming investor conferences
GlobeNewswire
·
April 2, 2025
Immunocore to present at upcoming investor conferences (OXFORDSHIRE, England …
Cerence AI Honored with 2025 ECARX Best Contribution Award
GlobeNewswire
·
April 2, 2025
SHANGHAI and BURLINGTON, Mass., April 02, 2025 (GLOBE NEWSWIRE) -- Cerence Inc. (NASDAQ: CRNC) (“Cerence AI”), a global leader pioneering conversational AI-powered user experiences, today announced that it has received a Best Contribution Award at the 2025 …
Akoya Biosciences and Team SAMBAI Announce Selection of the PhenoCycler®-Fusion as the Foundational Spatial Proteomics Technology for Large-Scale Study to Address Cancer Inequities
GlobeNewswire
·
April 2, 2025
Akoya’s technology to generate data for a first-of-its-kind Biobank and Data Repository for Cancer Equity Research, funded through the Cancer Grand Challenges initiative The unprecedented scale of the initiative requires the high plex and high throughput …
Immuneering to Present at the 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire
·
April 2, 2025
CAMBRIDGE, Mass., April 02, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and commercialize more effective and better tolerated therapies for cancer patients, today announced that …
LVT Releases Industry-First Mobile Security Unit Talk Down Powered by Agentic AI and Other Features
GlobeNewswire
·
April 2, 2025
LAS VEGAS, April 02, 2025 (GLOBE NEWSWIRE) -- (ISC West Booth #29061), April 2, 2025: LVT (LiveView Technologies, Inc.), the leader of rapidly deployable security solutions, today announced multiple new capabilities powered by proprietary AI models that …
ESET Doubles Down on North American Corporate Solutions Business with New Field CISO
GlobeNewswire
·
April 2, 2025
LAS VEGAS, April 02, 2025 (GLOBE NEWSWIRE) -- ESET, a global leader in cybersecurity, is growing its Corporate Solutions business in North America with the appointment of Charles (Chuck) Everette as Field Chief Information Security Officer (CISO). …
Lexicon Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire
·
April 2, 2025
THE WOODLANDS, Texas, April 02, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a presentation at the 24th Annual Needham Virtual Healthcare Conference 2025 on Wednesday, …
Opus Genetics to Participate in Upcoming Investor Conference in April
GlobeNewswire
·
April 2, 2025
RESEARCH TRIANGLE PARK, N.C., April 02, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage ophthalmic biotechnology company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and therapies for other …
Immutep to Participate in Upcoming Investor Conferences
GlobeNewswire
·
April 2, 2025
SYDNEY, AUSTRALIA , April 02, 2025 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a late-stage immunotherapy company targeting cancer and autoimmune diseases, today announces its management will present and …
Tiziana Life Sciences Announces Johns Hopkins University Commences Dosing Nasal Foralumab in Phase 2 Multiple Sclerosis Clinical Trial
GlobeNewswire
·
April 2, 2025
NEW YORK, April 02, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a …
Ovid Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire
·
April 2, 2025
NEW YORK, April 02, 2025 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company dedicated to developing medicines for brain conditions with significant unmet need, today announced that Meg Alexander, President and Chief …
Infinidat Earns 5-Star Rating in the 2025 CRN® Partner Program Guide for the Fourth Consecutive Year
GlobeNewswire
·
April 2, 2025
WALTHAM, Mass., April 02, 2025 (GLOBE NEWSWIRE) -- Infinidat, a leading provider of enterprise storage solutions, today announced that the company has been recognized by CRN®, a brand of The Channel Company, with a 5-Star Award in the 2025 CRN Partner …
Palvella Therapeutics Announces Late-Breaking Oral Presentation at the 15th World Congress of Pediatric Dermatology
GlobeNewswire
·
April 2, 2025
WAYNE, Pa., April 02, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PVLA) Palvella Therapeutics, Inc. (Palvella or “the Company”), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from …